
News and Publications
Always Well Informed
Stay up to date on international case law, significant changes to the law and important news at HOFFMANN EITLE. Click the button below to subscribe to our newsletter.
UPC_CFI_359/2023, UPC_CFI_365/2023, UPC_CFI_702/2024: Mannheim grants first injunction for UK infringement; Paris confirms jurisdiction for Lugano state (Switzerland) infringement
(1) Court docket: LD Mannheim, decisions of 18 July 2025 – UPC_CFI_365/2023 [EP 3 511 174] and UPC_CFI_359/2023 [EP 3 476 616](1) Parties: FUJIFILM Corporation vs. Kodak GmbH/Kodak Graphic Communic...
find out moreG 1/23 - EPO no longer requires products to be enabled to form prior art
On July 2, 2025, the Enlarged Board of Appeal published the decision G 1/23 “Solar Cell”, in which HOFFMANN EITLE was heavily involved as representative of our long-standing client Mitsui Chemicals...
find out moreHOFFMANN EITLE congratulates newly qualified European Patent Attorneys
We are very proud to announce the HOFFMANN EITLE colleagues who have successfully qualified as a European Patent Attorney this year.Congratulations go to: Christina Courreges (Biotechnology, Munic...
find out moreUPC launches first phase of new Case Management System on 8 July 2025
The Unified Patent Court (UPC) will roll out the first phase of its new Case Management System (CMS) on Tuesday, 8 July 2025. To prepare for the launch, the current CMS will be unavailable from 3 J...
find out moreHOFFMANN EITLE recognized in IP STARS 2025 Rankings
We’re proud to announce that HOFFMANN EITLE has once again been recognized as one of Europe’s leading IP law firms in the 2025 IP STARS rankings by Managing IP: Tier 1 – Patent Prosecution (Patent...
find out moreUPC CFI 140/2024: LD Düsseldorf provides further guidance on claim interpretation in 10x Genomics vs. Curio Bioscience infringement decision
Court docket: LD Düsseldorf, decisions of 16.04.2025 - CFI 140/2024 [EP 2 697 391]Parties: 10x Genomics v. Curio Bioscience Inc. Contributor: Sebastian Giese Headnote As claim construction is a mat...
find out moreHOFFMANN EITLE recognized in Leaders League Rankings 2025
HOFFMANN EITLE has once again been recognized in the Leaders League 2025 rankings, earning distinctions across four key categories. The firm received the following ratings: "Leading" in th...
find out moreG 1/24 - The description always to be consulted for claim interpretation
In a landmark ruling on June 18, 2025, the Enlarged Board of Appeal of the European Patent Office issued its decision in referral G 1/24, settling a long-standing debate over how patent claims shou...
find out moreHOFFMANN EITLE Quarterly Newsletter 06/25
Dear Colleagues and Friends, In this issue of the Hoffmann Eitle Quarterly we begin with an analysis of the EU Commission’s long-awaited Teva decision, addressing the use - and alleged misuse - of...
find out moreHOFFMANN EITLE ranked in Financial Times Europe’s Leading Patent Law Firms 2025 Survey
We’re pleased to share that HOFFMANN EITLE has been named one of Europe’s leading patent law firms in the latest Financial Times rankings. Based on a comprehensive survey conducted by Statista, the...
find out more